Literature DB >> 20138800

miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.

Shu-Chun Lin1, Chung-Ji Liu, Jung-An Lin, Wei-Fan Chiang, Pei-Shih Hung, Kuo-Wei Chang.   

Abstract

MicroRNAs (miRNAs) play important roles in neoplastic process. miR-24 is localized on chromosome 9q22 and 19p13, regions frequently altered in oral squamous cell carcinoma (OSCC). This study showed that miR-24 was up-regulated in OSCC tissues relative to control samples. In addition, the plasma levels of miR-24 in OSCC patients were significantly higher than in control individuals. miR-24 expression was also higher in OSCC cell lines relative to normal oral keratinocytes. Experiments blocking miR-24 and using exogenous miR-24 expression indicated that miR-24 contributes to the growth of OSCC cells and that miR-24 may target p57. This study suggests that miR-24 is involved in the regulation of OSCC growth and that the miR-24's level in plasma may be validatable as a tumor marker for OSCC patients. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138800     DOI: 10.1016/j.oraloncology.2009.12.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  58 in total

1.  Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer.

Authors:  Guibin Zhao; Lijie Liu; Tianshu Zhao; Shoude Jin; Sibo Jiang; Shouqiang Cao; Jingquan Han; Yanzhong Xin; Qing Dong; Xian Liu; Jian Cui
Journal:  Tumour Biol       Date:  2015-03-01

2.  Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma.

Authors:  Xiong Liu; Hua-Nan Luo; Wen-Dong Tian; Juan Lu; Gang Li; Lu Wang; Bao Zhang; Bi-Jun Liang; Xiao-Hong Peng; Shao-Xiong Lin; Ying Peng; Xiang-Ping Li
Journal:  Cancer Biol Ther       Date:  2013-08-23       Impact factor: 4.742

3.  STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.

Authors:  Zhe Liu; Hong Li; Sumeng Fan; Hui Lin; Wenwei Lian
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

Review 4.  Noninvasive micromarkers.

Authors:  Janani Saikumar; Krithika Ramachandran; Vishal S Vaidya
Journal:  Clin Chem       Date:  2014-01-09       Impact factor: 8.327

5.  Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.

Authors:  Jia-Yu Yin; Zhao-Qun Deng; Feng-Qiong Liu; Jun Qian; Jiang Lin; Qin Tang; Xiang-Mei Wen; Jing-Dong Zhou; Ying-Ying Zhang; Xiao-Wen Zhu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

6.  Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation.

Authors:  Sumei Wang; Rong Zhang; Francois X Claret; Huiling Yang
Journal:  Mol Cancer Ther       Date:  2014-10-15       Impact factor: 6.261

7.  Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma.

Authors:  Mohaddese Maghsudlu; Ehsan Farashahi Yazd; Taghi Amiriani
Journal:  J Gastrointest Cancer       Date:  2020-03

8.  MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma.

Authors:  Xiqiang Liu; Anxun Wang; Caroline E Heidbreder; Lu Jiang; Jinsheng Yu; Antonia Kolokythas; Lei Huang; Yang Dai; Xiaofeng Zhou
Journal:  FEBS Lett       Date:  2010-09-04       Impact factor: 4.124

Review 9.  Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases.

Authors:  Ravindresh Chhabra; Richa Dubey; Neeru Saini
Journal:  Mol Cancer       Date:  2010-09-03       Impact factor: 27.401

10.  microRNAs carried by exosomes promote epithelial-mesenchymal transition and metastasis of liver cancer cells.

Authors:  Qin-Lian Chen; Chun-Feng Xie; Kun-Liang Feng; Dong-Ying Cui; Shui-Lian Sun; Jun-Chang Zhang; Cheng-Ming Xiong; Jun-Hai Huang; Zhong Chong
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.